Identifying, managing, mitigating, analyzing, and tracing risk is recommended for medical device development by ISO 14971 and the FDA. But how do you ensure risk is visible throughout your development cycle? Traceability is one way you can easily expose these risk artifacts as part of your overall risk strategy.